Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer

NCT00278148 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: carboplatin
DRUG: Erlotinib
DRUG: paclitaxel
PROCEDURE: conventional surgery
RADIATION: radiation therapy

Sponsor

Nathan Pennell, MD, PhD

Collaborators

[object Object]